Shared features of pathogenetic aspects, autoimmunity and pharmacotherapy in coronavirus infection (COVID-19) and immunoinflammatory rheumatic diseases-Reference-Cited by-同舟云学术

Shared features of pathogenetic aspects, autoimmunity and pharmacotherapy in coronavirus infection (COVID-19) and immunoinflammatory rheumatic diseases

Published:2022-10-19 Issue:5 Volume:16 Page:82-87
ISSN:2310-158X
Container-title:Modern Rheumatology Journal
language:
Short-container-title:Sovremennaâ revmatologiâ

Author:

Rutskaya-Moroshan K. S.¹^ORCID,Abisheva S. T.¹^ORCID,Lila A. M.²^ORCID

Affiliation:

1. Astana Medical University

2. V.A. Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuing Professional Education

Abstract

The review is devoted to the relationship between the pathogenetic mechanisms of coronavirus infection (COVID-19) and immunoinflammatory rheumatic diseases (IRD). The current knowledge on the pathogenesis of COVID-19 is summarized, including the mechanisms of coagulopathy, hyperproduction of pro-inflammatory cytokines, and antiphospholipid antibodies that are common with IRD. The presence and clinical significance of detection of various autoantibodies in COVID-19, which probably play a pathogenetic role in immune dysregulation, were analyzed. Based on the data of recent studies, risk factors and features of the severe course of infection in patients with IRD are considered.

Publisher

IMA Press, LLC

Subject

Pharmacology (medical),Immunology,Immunology and Allergy,Rheumatology

Reference60 articles.

1. Tentolouris A, Ntanasis-Stathopoulos I, Vlachakis PK, et al. COVID-19: time to flatten the infodemic curve. Clin Exp Med. 2021 May;21(2):161-5. doi: 10.1007/s10238-020-00680-x. Epub 2021 Jan 8.

2. Nasonov EL. Coronavirus disease 2019 (COVID-19) and autoimmunity. Nauchnoprakticheskaya revmatologiya. 2021;59(1): 5-30. (In Russ.).

3. Nasonov EL. Coronavirus disease 2019 (COVID-19): contribution of rheumatology. Terapevticheskii Arkhiv. 2021;(5):537–50. (In Russ.).

4. Hamming I, Timens W, Bulthuis M, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004 Jun;203(2):631-7. doi: 10.1002/path.1570.

5. Parasher A. COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgrad Med J. 2021 May; 97(1147):312-20. doi: 10.1136/postgradmedj-2020-138577.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimalarial Drugs at the Intersection of SARS-CoV-2 and Rheumatic Diseases: What Are the Potential Opportunities?;Medicina;2024-07-19

2. Evaluation of morphological parameters, PLR and NLR inflammation indicators in patients with long-term COVID-19 of mild and severe complexity;Polish Annals of Medicine;2024-04-24